COMPANY
Dialectic Therapeutics
Dialectic Therapeutics is a biotechnology company. From company website Source · Oct 12, 2026
Timeline
- Trial start Phase 1: A Study of DT2216 in Relapsed/Refractory Malignancies source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT04886622 | A Study of DT2216 in Relapsed/Refractory Malignancies | Phase 1 | Completed | Aug 25, 2021 | Jun 30, 2024 (actual) |